MedPath
HSA Approval

LENDOMAX TABLET 70MG

SIN14606P

LENDOMAX TABLET 70MG

LENDOMAX TABLET 70MG

September 8, 2014

PAN-MALAYAN PHARMACEUTICALS PTE LTD

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPAN-MALAYAN PHARMACEUTICALS PTE LTD
Licence HolderPAN-MALAYAN PHARMACEUTICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

M05BA04

alendronic acid

Manufacturer Information

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Intas Pharmaceuticals Ltd

Active Ingredients

Alendronate Sodium 91.37mg eqv to Alendronate Acid

70mg

Alendronic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LENDOMAX TABLET 70MG - HSA Approval | MedPath